Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hodgkin Disease × tislelizumab × Clear all

Phase

Status

Not yet recruiting 2 Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 18 Stomach Neoplasms 11 Carcinoma, Hepatocellular 10 Squamous Cell Carcinoma of Head and Neck 7 Esophageal Squamous Cell Carcinoma 7 Colorectal Neoplasms 7 Lung Neoplasms 6 Advanced Solid Tumor 4 Triple Negative Breast Neoplasms 3 Head and Neck Neoplasms 3 Esophageal Neoplasms 3 Urinary Bladder Neoplasms 2 Small Cell Lung Carcinoma 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Neoplasms 2 Neoplasm, Residual 2 Nasopharyngeal Carcinoma 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Cholangiocarcinoma 2 Squamous Cell Carcinoma of External Auditory Canal 1 Solid Tumor, Adult 1 Solid Tumor 1 Small Cell Lung Cancer Extensive Stage 1 Simpson-Golabi-Behmel syndrome 1 Sarcoma 1 Renal Pelvic Carcinoma 1 Recurrence 1 Pseudomyxoma Peritonei 1

Interventions

Cyclophosphamide 10 Nivolumab 7 pembrolizumab 6 fludarabine 6 Gemcitabine 6 Brentuximab Vedotin 6 Etoposide 5 Doxorubicin 5 Dexamethasone 5 Dacarbazine 5 fludarabine phosphate 4 Whole-Body Irradiation 4 Vinblastine 4 Mycophenolic Acid 4 Melphalan 4 Filgrastim 4 Blood Specimen Collection 4 Vinorelbine 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Granulocyte Colony-Stimulating Factor 3 Cytarabine 3 pegfilgrastim 2 X-Rays 2 Vincristine 2 Tacrolimus 2 Stem Cell Transplantation 2 Rituximab 2 Cisplatin 2 Carmustine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05977673 2025-12-08

FIL_Tisle-HL

Fondazione Italiana Linfomi - ETS

Phase 2 Recruiting

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡